Thyroid cancer genetics: how close are we to personalizing clinical management?
News & Views in … Personalized Medicine
Study suggests three genes are associated with post-traumatic stress disorder
Sequencing technology identifies new approaches for personalizing cancer treatment
General Electric grant awarded to Moffitt researcher's mission to offer personalized treatment for metastatic breast cancer
Research reveals novel genes mutated in stomach cancer
Research Highlights: Highlights from the latest articles in personalized cardiovascular medicine
Biomarkers and genetic polymorphisms in stable coronary heart disease
Biomarkers predicting outcomes in the PEACE trial
Renin–angiotensin–aldosterone system polymorphisms and CHD severity
NPY polymorphisms, metabolic syndrome and CHD
Conference Scene: Personalized medicine: changing the healthcare paradigm
CYP2D6*4 polymorphism, tramadol treatment and its clinical impact in patients with postherpetic neuralgia
Pharmacogenomics: assessing educational exposure, confidence in knowledge and training elements of pharmacists
Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular disease
Healthcare reform: it is getting personal
Economic challenges and possible policy actions to advance stratified medicine
After the revolution? Ethical and social challenges in ‘personalized genomic medicine’
Clinical decision support for personalized medicine: an opportunity for pharmacist–physician collaboration
Population-based screening in the era of genomics
Acknowledgements